Enable JavaScript to visit this website.

What is XELJANZ/XELJANZ XR?

XELJANZ/XELJANZ XR (tofacitinib) is a prescription medicine called a Janus kinase (JAK) inhibitor used to treat:

  • Adults with active psoriatic arthritis in which methotrexate or other similar medicines called nonbiologic disease-modifying antirheumatic drugs (DMARDs) did not work well.

It is not known if XELJANZ/XELJANZ XR is safe and effective in children or in people with Hepatitis B or C.

XELJANZ/XELJANZ XR is not recommended for people with severe liver problems.

XELJANZ CO-PAY SAVINGS CARD

Our Co-Pay Savings Card may make XELJANZ/XELJANZ XR more affordable for eligible patients with private insurance. Terms and conditions/eligibility requirements apply.

For patients who do not have private insurance, XELSOURCE may offer financial assistance for government-funded and uninsured patients through the Pfizer Patient Assistance Program. Call XELSOURCE to learn more about these programs. Terms and conditions/eligibility requirements apply.